PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

295 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
81.
Khamis, A.* et al.: Pnliprp1 hypermethylation in human exocrine pancreas reveals a link between diabetes and pancreatic cancer. Diabetologia 63, 1, S109-S109 (2020)
82.
Koivula, R.W.* et al.: The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: An IMI DIRECT study. Diabetologia 63, 744-756 (2020)
83.
Koivula, R.W.* et al.: Correction to: The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study (Diabetologia, (2020), 63, 4, (744-756), 10.1007/s00125-019-05083-6). Diabetologia 64, 260-261 (2020)
84.
Kullmann, S. et al.: Empagliflozin improves insulin sensitivity of the hypothalamus in humans with prediabetes. Diabetologia 63, 1, S13-S14 (2020)
85.
Kwon, B.* et al.: A visual analytics method to explore the evolution of autoantibodies during progression to type 1 diabetes in multi-site birth cohort studies. Diabetologia 63, 1, S159-S159 (2020)
86.
Lamprinou, A.* et al.: Evaluation of determinants of hepatic insulin clearance: a Mendelian randomisation study. Diabetologia 63, 1, S36-S37 (2020)
87.
Marinicova, Z. et al.: Presentation of insulin granule derived peptides on MHC I in Enterovirus-infected beta cells and type 1 diabetes. Diabetologia 63, 1, S111-S111 (2020)
88.
Mattila, M.* et al.: Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: The TEDDY study. Diabetologia 63, 278-286 (2020)
89.
Oquendo, M.B. et al.: Comparison between in vitro differentiation of pancreatic and subcutaneous adipocytes of subjects with normal glucose tolerance. Diabetologia 63, 1, S254-S255 (2020)
90.
Scarale, M.* et al.: Circulating metabolites significantly improve the prediction of renal dysfunction in type 2 diabetes. Diabetologia 63, 1, S3-S3 (2020)
91.
Scarale, M.* et al.: Building clinical risk score systems for predicting all-cause and cardiovascular-specific mortality among type 2 diabetes patients. Diabetologia 63, S3-S4 (2020)
92.
Suleiman, M.* et al.: Glucose-lowering therapy and ex-vivo beta cell function in type 2 diabetes. Diabetologia 63, 1, S196-S196 (2020)
93.
van Krieken, P.P.* ; Odermatt, T.S.* ; Blüher, M. ; Wueest, S.* & Konrad, D.*: Oncostatin M inhibits browning of white adipose tissue via gp130 signalling. Diabetologia 63, 1, S21-S22 (2020)
94.
Vasiljevic, J. ; Torkko, J.M. ; Knoch, K.-P. & Solimena, M.: The making of insulin in health and disease. Diabetologia 63, 1981-1989 (2020)
95.
Vasiljevic, J. et al.: Post-transcriptional co-regulation of insulin secretory granule proteins. Diabetologia 63, 1, S7-S8 (2020)
96.
Vosseler, A. et al.: Postprandial thermogenesis is reduced in obesity. Diabetologia 63, 1, S258-S258 (2020)
97.
Wagner, L. et al.: Exercise changes neuronal processing of food cues in sedentary overweight and obese adults. Diabetologia 63, 1, S98-S98 (2020)
98.
Wigger, L.* et al.: Cross-sectional multi-omics insight from islet and plasma samples into the progression to type 2 diabetes in metabolically profiled pancreatectomised surgical donors. Diabetologia 63, 1, S106-S106 (2020)
99.
Ziegler, A.-G. & Bonifacio, E.: Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes? Diabetologia, DOI: 10.1007/s00125-020-05175-8 (2020)
100.
Eugster, A.* et al.: Cytoplasmic ends of tetraspanin 7 harbour epitopes recognised by autoantibodies in type 1 diabetes. Diabetologia 62, 805-810 (2019)